Conf. Dr. Abil. Dana Lucia Stănculeanu

Medic Primar Oncologie Medicală, IOB,

Președinte SNOMR

Dr. Mircea Dediu

Medic Primar Oncologie Medicală,

Centrul Oncologic Sanador

Prof. Dr. Diana Ionescu

Consultant Pathologist

University of British Columbia, Vancouver, CA

Prof. Dr. Laura Mazilu

Medic Primar Oncologie Medicală,

Spitalul Clinic Ovidius, Constanța

Prof. Dr. David Gandara

Professor of Medicine Emeritus,

Univ. of California, CA, USA

Prof. Dr. Barbara Melosky

Professor of Medicine, UBC; Medical Oncologist,

BC Cancer, Vancouver, BC

Prof. Dr. Normand Blais

Hematologist and medical oncologist

Univ. of Montreal and McGill Univ, QC, Canada

Prof. Dr. David Hong

Professor and Deputy Chair,

MD Anderson Cancer Center, USA

Dr. Anna McGuire

Clinical Associate Professor, Univ. of British Columbia

Director, Minimally Invasive Thoracic Fellowship

Dr. Alina Mihai

Clinical Associate Professor,

UCD School of Medicine, Dublin, Ireland

Dr. Dana Clement

Medic Primar Oncologie Medicală,

Institutul Regional de Oncologie Iași

Dr. Amedeia Lavinia Niță

Medic Primar Oncologie Medicală

Spitalul Municipal Ploiești

Prof. Dr. Tudor Ciuleanu

Medic Primar Oncologie Medicală,

Institutul Oncologic Cluj

Prof. Dr. Lyudmila Bazhenova

Clinical Professor of Medicine,

UC San Diego Moores Cancer Center, CA, USA

09:00 AM – 09:05 AM – Opening Ceremony – Conf. Dr. Abil. Dana Lucia Stănculeanu

09:05 AM – 09:35 AM – Adjuvant vs neoadjuvant ICI in resectable NSCLC – Prof. Dr. Laura Mazilu

09:35 AM -10:05 AM – Unity in diversity: Antibody drug conjugates in the treatment of NSCLC – Dr. Mircea Dediu

10:05 AM – 10:20 AM – Coffee Break

10:20 AM – 10:50 AM – AstraZeneca Symposium: From early to late stage in NSCLC – Dr. Mircea Dediu

10:50 AM – 11:35 AM – Treatment options for patients progresing on Osimertinib – Prof. Dr. David Gandara

11:35 AM – 12:05 PM – Targeted therapy for rare oncogene-driven NSCLC – Prof. Dr. Barbara Melosky

12:05 PM – 12:35 PM – Neuroendocrine tumors of the lung: the old and the new – Prof. Dr. Diana Ionescu

12:35 PM – 12:50 PM – Pfizer Symposium: Optimizarea tratamentului în linia 1 de tratament în NSCLC ALK+ -> rolul și importanța Lorlatinib – Dr. Mircea Dediu

12:50 PM – 01:00 PM – Takeda Symposium: Exploring ALUNBRIG’s (brigatinib) role in optimizing First-line therapy for NSCLC ALK+ patients requiring rapid and long-lasting intracranial protection – Prof. Dr. Laura Mazilu

01:00 PM – 02:00 PM – Lunch Break

02:00 PM – 02:30 PM – Keynotes vs CheckMate 9LA – Prof. Dr. Normand Blais

02:30 PM – 03:00 PM – Cracking KRAS: Clinical perspective from Lung Cancer – Prof. Dr. David S. Hong

03:00 PM – 03:40 PM – Debate session – Surgery against Radiotherapy Stage IIIA NSCLC : do we have a favourite  treatment strategy ?

• Favouring Surgery – Dr. Anna McGuire
• Favouring Radiation – Dr. Alina Mihai

03:40 PM – 03:55 PM – Coffee Break

03:55 PM – 04:05 PM – Angelini Symposium – Management of emesis in lung cancer patients – Dr. Dana Clement

04:05 PM – 04:35 PM – MSD Symposium – Treatment options for PD-L1 low/non expressors mNSCLC patients – Dr. Amedeia Lavinia Niță

04:35 PM – 04:50 PM – Roche Symposium: Updates in LC treatment landscape: from targeted to IO and more – Dr. Mircea Dediu

04:50 PM – 05:20 PM – Brain metastases in NSCLC: local or systemic therapy? – Prof. Dr. Tudor Ciuleanu

05:20 PM – 05:40 PM – A brief overview of the current status and future perspectives in NSCLC management – Prof. Dr. Lyudmila Bazhenova

05:40 PM – 06:00 PM – BMS Symposium – O nouă perspectivă terapeutică în 1L NSCLC – Prof. Dr. Laura Mazilu

06:00 PM – 06:20 PM – Eli Lilly Symposium – Cyramza – I’m ready to do what it takes! – Prof. Dr. Laura Mazilu

06:20 PM – 06:35 PM – Sanofi Symposium – CEMIPLIMAB – Noua armă în arsenalul de luptă împotriva cancerului pulmonar (NSCLC) – Dr. Mircea Dediu

06:35 PM – 06:45 PM – Conclusions and Closing Ceremony – Conf. Dr. Abil. Dana Lucia Stănculeanu